+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celyad - logo

Celyad SA, a clinical-stage biopharmaceutical company, focuses on engineered cell therapy treatments. It develops therapeutic therapies for the treatment of unmet medical needs in cardiology and oncology. The company's best known product is the C-Cure, an autologous cell therapy for the treatment of heart failure. The company was formerly known as Cardio3 BioSciences SA and changed its name to Celyad SA in May 2015. Celyad SA was founded in 2004 and is based in Mont-Saint-Guibert, Belgium.

From
From
Ovarian Cancer (Oncology) - Drugs in Development, 2021 - Product Thumbnail Image

Ovarian Cancer (Oncology) - Drugs in Development, 2021

  • Report
  • December 2021
  • 5066 Pages
From
Myelodysplastic Syndrome - Pipeline Insight, 2021 - Product Thumbnail Image

Myelodysplastic Syndrome - Pipeline Insight, 2021

  • Drug Pipelines
  • September 2021
  • 60 Pages
From
From
CAR T-cell Therapy - Pipeline Insight, 2022 - Product Thumbnail Image

CAR T-cell Therapy - Pipeline Insight, 2022

  • Clinical Trials
  • January 2022
  • 60 Pages
From
CAR-T Cell Therapy Market Review - Product Thumbnail Image

CAR-T Cell Therapy Market Review

  • Report
  • December 2019
  • 59 Pages
From
From
From
The Global Market for Stem Cells - Product Thumbnail Image

The Global Market for Stem Cells

  • Report
  • March 2018
  • 162 Pages
From
From
From
Loading Indicator